Grant: NATIONAL JEWISH HEALTH
Primary Recipient
NATIONAL JEWISH HEALTH
Amount
$9,746,871.00
Award Date
9/25/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Chronic lung diseases represent a broad spectrum of chronic fibrosing/inflammatory lung conditions that are for the most part poorly responsive to treatment and often fatal. COPD/emphysema is the fourth leading cause of death in the United States and the
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
TRUSTEES OF BOSTON UNIVERSITY | Sub-recipient | $2,739,322.00 |
UNIVERSITY OF PITTSBURGH THE | Sub-recipient | $2,201,163.00 |
DANA-FARBER CANCER INSTITUTE, INC. | Sub-recipient | $1,870,313.00 |
NATIONAL JEWISH HEALTH | Primary recipient | $1,473,970.39 |
REGENTS OF THE UNIVERSITY OF COLORADO, THE | Sub-recipient | $1,346,246.61 |
MAYO CLINIC | Sub-recipient | $77,459.00 |
REGENTS OF THE UNIVERSITY OF MICHIGAN | Sub-recipient | $38,397.00 |
Vendors Connected to Award
Vendor | Role | Amount |
---|---|---|
Applied Biosystems, Inc | Primary vendor | $119,938.20 |
Lewan & Associates | Primary vendor | $103,277.00 |
Roche Diagnostics Corp | Primary vendor | $110,300.00 |
SciGene | Primary vendor | $42,675.00 |
Applied Biosystems, Inc | Primary vendor | $303,127.13 |
Roche Diagnostics Corp | Primary vendor | $82,417.50 |
Roche Diagnostics Corp | Primary vendor | $40,500.00 |
Roche Diagnostics Corp | Primary vendor | $83,205.00 |
Roche Diagnostics Corp | Primary vendor | $77,624.80 |
Roche Diagnostics Corp | Primary vendor | $166,064.80 |
Roche Diagnostics Corp | Primary vendor | $166,364.80 |
Illumina, Inc | Sub-vendor | $154,204.10 |
Agilent Technologies, Inc | Sub-vendor | $37,816.02 |